Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications

This study has been completed.
Information provided by:
Abbott Identifier:
First received: March 22, 2008
Last updated: March 26, 2008
Last verified: March 2008
To compare the taste and smell acceptability scores of cefdinir (Omnicef) versus amoxicillin oral antibiotic suspension medications in pediatric subjects. It was designed to determine if Omnicef or amoxicillin is preferred to the other with regard to taste or smell.

Condition Intervention Phase
Drug: cefdinir (Omnicef)
Drug: amoxicillin
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Participant)
Official Title: A Comparative, Multi-Center, Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic Suspension Medications

Resource links provided by NLM:

Further study details as provided by Abbott:

Primary Outcome Measures:
  • Taste/smell acceptance [ Time Frame: 2 hours ]

Secondary Outcome Measures:
  • Adverse events assessment [ Time Frame: 72 hours with follow-up to a satisfactory conclusion ]
  • Concomitant Medications [ Time Frame: 72 hours ]
  • Vital signs [ Time Frame: 2 hours ]
  • Any clinically abnormal observations [ Time Frame: 2 hours with follow-up to a satisfactory conclusion ]

Enrollment: 158
Study Start Date: January 2003
Primary Completion Date: January 2003 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 Drug: cefdinir (Omnicef)
2.5 ml of strawberry cream flavored oral suspension 125 mg/5 ml
Other Names:
  • ABT-198
  • Omnicef
  • cefdinir
Active Comparator: 2 Drug: amoxicillin
2.5 ml of bubble-gum flavored amoxicillin oral suspension 125 mg/5 ml

Detailed Description:
The Primary Purpose for the study is "Other". Per, more information regarding the primary purpose is provided here; this study is a pediatric taste test.

Ages Eligible for Study:   4 Years to 8 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Female or male child age 4 through 8 years in good general health.
  • Minimum weight of 16.3 kg (36 lb).
  • Willing to comply with appropriate instructions provided to complete the study.
  • Written informed consent from parent/legal guardian.

Exclusion Criteria:

  • Current medical condition, that in the opinion of the Investigator or designee, may interfere with the ability to discriminate taste (e.g., common cold, sinus infection, bronchial infection, etc.).
  • History of allergic reaction to cefdinir, prescription (e.g. penicillins or cephalosporins) and/or OTC medications, and/or food products. History of significant medical condition (e.g., GI disorders, hematological or bleeding disorders, renal or hepatic diseases).
  • Use of any oral medication, vitamins or herbal supplements within 6 hours prior to tasting.
  • Temperature > than 99.2°F.
  • Participation in a clinical or marketing research study within the past 3 months.
  • Sibling of another subject on the study, or living in the same household as another subject that has participated in a clinical or marketing research study within the past 3 months.
  • Family member or close friend employed by an advertising agency, market research company, and/or a company that processes or manufacturers medical or health care products.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00644891

United States, Arizona
Scottsdale, Arizona, United States, 85251
United States, Florida
St. Petersburg, Florida, United States, 33710
United States, Ohio
Miamiville, Ohio, United States, 45147
Sponsors and Collaborators
  More Information

Responsible Party: Angela M Nilius, Abbott Identifier: NCT00644891     History of Changes
Other Study ID Numbers: M02-569
Study First Received: March 22, 2008
Last Updated: March 26, 2008

Keywords provided by Abbott:
Pediatric taste test
Antibiotic taste test

Additional relevant MeSH terms:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Antitubercular Agents processed this record on May 24, 2017